Auro Laboratories Ltd
company logo

Auro Laboratories Ltd

Auro Labs. Share Price

Pharmaceuticals
Small Cap

-

0 (0%)

Start Investing in Auro Laboratories Ltd

*By signing up you agree to our Terms and Conditions

Auro Laboratories Ltd Performance

-

-

-

-


-

-

-

-

-

Auro Laboratories Ltd Fundamentals

148.74Cr

19.13

3.55

0.43

12.48

0%

67.35

i buttonClick here to know more about Fundamentals

Auro Laboratories Ltd Financials

Auro Laboratories Ltd Financialsright-arrow

Auro Laboratories Ltd Shareholding Pattern

Auro Laboratories Ltd Delivery and Volume

About Auro Laboratories Ltd

Auro Laboratories Ltd, founded in 1992, has been manufacturing and providing generic Active Pharmaceutical Ingredients (API). Currently, the Company is specializing in producing Anti Diabetics like Metformin HCL. It is the first-line treatment for type 2 diabetes. The Company is headquartered in Mum

Sharat Deorah

1989

-

NameDesignation
Sharat DeorahChairman & Managing Director
Siddhartha DeorahWhole-time Director
Kavita Vijayakant SharmaIndependent Director
Kiran KulkarniWhole-time Director
Sweta AgarwalCompany Sec. & Compli. Officer
Vishal Kailash Chandra JhunjhunwalaIndependent Director
Mahendra Kumar DagaIndependent Director
News and Events...

Similar Stocks

What's Trending

View All
View All

Auro Laboratories Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Auro Laboratories Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Auro Laboratories Ltd's share price is ₹238.75 as of 2024-10-30.
Auro Laboratories Ltd's P/E ratio is 19.13 times as of 2024-10-30.
Auro Laboratories Ltd's most recent financial reports indicate a price-to-book ratio of 3.55, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Auro Laboratories Ltd's market capitalization is ₹148.74 Cr as on 2024-10-30.
The current financial records of Auro Laboratories Ltd show a 20.46% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Auro Laboratories Ltd's most recent financial filings, the company has a total asset value of ₹30.85, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Auro Laboratories Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Auro Laboratories Ltd's 52-week high and low as of 2024-10-30 are ₹245 and ₹214.1, respectively.